Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT07011537Not ApplicableEnrolling By Invitation

Examining the Impact of a Digital Health Program and TENS Device for Patients With Chronic Low Back Pain

Role: collaborator

NCT05198245Active Not Recruiting

Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

Role: collaborator

NCT06379529Not ApplicableNot Yet Recruiting

The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events

Role: collaborator

NCT02520362Completed

Denosumab Safety Assessment in Multiple Observational Databases

Role: collaborator

NCT04974580Phase 4Completed

Research and Innovation to Stop E-cigarette/Vaping in Young Adults

Role: collaborator

NCT05175651Not ApplicableNot Yet Recruiting

Prospective Electronic Polygenic Risk Study - Second Phase

Role: collaborator

NCT02662153Completed

Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics

Role: collaborator

NCT04656691Phase 4Terminated

At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19

Role: collaborator

NCT02805283Completed

Dapagliflozin Patient Satisfaction Survey

Role: collaborator

NCT03168451Not ApplicableCompleted

American Indians STOp Smoking by Mobile Phone

Role: collaborator

NCT03078049Completed

Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data

Role: collaborator

NCT02406235Completed

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Role: collaborator

All 12 trials loaded